In the News

Recent Coverage of HMS in the News
July 3, 2012

Nearly two-thirds of American teenagers admit to having "anger attacks" that involve destroying property, threatening or engaging in violence, a new study found. And one in 12 has intermittent explosive disorder, characterized by chronic, uncontrollable fits of rage. Ronald Kessler, the McNeil Family Professor of Health Care Policy at HMS, is the lead author of the study.

July 3, 2012

A biotech company in Cambridge called Genocea believes it can create the first effective T-cell vaccines. Darren Higgins, HMS professor of microbiology and immunobiology, is a cofounder of Genocea.

July 3, 2012

A new health services business is looking to catch what its founder sees as an emerging third wave in the clinical application of genomics. Mark S. Boguski, HMS associate professor of pathology at the Center for Biomedical Informatics, is quoted.

July 2, 2012

Drinking more caffeinated coffee may help to lower the risk of developing basal cell carcinoma, the most common form of skin cancer, according to a new study. Jiali Han, HMS associate professor of dermatology at Brigham and Women’s Hospital, is the lead author of the paper.

July 2, 2012

Working with $2 million in new grants to be announced this week, the researchers for the Alzheimer’s Disease Neuroimaging Initiative will, for the first time, start mapping the DNA of 800 participants in a study attempting to find the root causes of memory loss. Robert Green, HMS lecturer on medicine at Brigham and Women’s Hospital, is coordinating the sequencing efforts.

July 2, 2012

Doctors have long viewed babies born at 37 or 38 weeks as full term, but new research suggests that infants are better off staying in a healthy womb longer, if possible. Tamara C. Takoudes, HMS clinical instructor in obstetrics, gynecology and reproductive biology at Beth Israel DeaconessMedical Center, is quoted.

July 1, 2012

Harvard Business School student Yi-An Huang and his wife, Kristin, HMS clinical fellow in medicine at Brigham and Women’s Hospital, have found a way to cut prescription drug prices for the poor in western Kenya.

June 29, 2012

As genetic testing spreads, revolutionizing how doctors recognize and treat illness, this deeply reported story finds the insurance industry in a muddle. A genetic test one insurer calls “actionable,” another considers “unnecessary.” Some will pay to test sick patients, but not to find out who’s at risk of a disease. Barrett Rollins, HMS professor of medicine and chief scientific officer at Dana-Farber Cancer Institute, and Allison Cirino, genetic counselor at Brigham and Women’s Hospital, are quoted.


Submit Photo Requests to HMS
To request photos from the HMS Office of Communications and External Relations, click here.


Tell us about your awards
Share news of your achievements with the larger HMS community.  Click here.


Book Reviews
If you are a faculty member who has published a book recently, click here.